{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T01:37:02Z","timestamp":1786757822540,"version":"build-2736575974"},"reference-count":13,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T00:00:00Z","timestamp":1111449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> A detailed assessment of West Nile virus (WNV) yield is needed to evaluate the effectiveness of the WNV nucleic acid amplification technology (NAT) screening implemented in 2003.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> WNV NAT screening and donation data were compiled from members of America's Blood Centers, which collect nearly 50\u2003percent of the US blood supply. WNV RNA screening was performed with either the Gen\u2010Probe\/Chiron Procleix transcription\u2010mediated amplification assay or the Roche TaqScreen polymerase chain reaction. Results of alternate NAT and WNV immunoglobulin M (IgM) antibody assays conducted on index and follow\u2010up samples were obtained from test manufacturers. Presumed WNV positivity was based on NAT repeat reactivity of the individual index donation whereas confirmatory status was based on additional IgM testing of the index donation and NAT and serology testing of follow\u2010up samples.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> From July through October 2003, 2.5\u2003million donations were screened for WNV RNA. Of 877 NAT\u2010reactive donations (screening positivity rate of 3.5 per 10,000 units), 430 (49%) were confirmed positive, whereas 68 (8%) lacking follow\u2010up data remained presumed positive. The sensitivity and positive predictive value of a presumed viremic result relative to final confirmatory status were 92 and 99\u2003percent, respectively. WNV activity was highest in the central plains with prevalence per 10,000 peaking August 1 to 15 in Colorado (67.7) and South Dakota (77.5) and August 16 to 31 in Wyoming (74.1) and North Dakota (102.0).<\/jats:p><jats:p><jats:bold>CONCLUSIONS:<\/jats:bold> WNV screening interdicted many viremic units, thereby reducing transfusion\u2010transmitted infections. This study demonstrates that a national collaborative effort facilitates timely surveillance of blood donor infectious disease prevalence rates.<\/jats:p>","DOI":"10.1111\/j.0041-1132.2005.04315.x","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T16:59:56Z","timestamp":1111510796000},"page":"469-479","source":"Crossref","is-referenced-by-count":66,"title":["The 2003 West Nile virus United States epidemic: the America's Blood Centers experience"],"prefix":"10.1111","volume":"45","author":[{"given":"Steven","family":"Kleinman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone A.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Pietrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Nemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,3,22]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1129","article-title":"Provisional surveillance summary of the West Nile Virus epidemic\u2014United States, January\u2010November 2002","volume":"51","author":"Centers for Disease Control and Prevention.","year":"2002","journal-title":"MMWR Morb Mortal"},{"issue":"3","key":"e_1_2_6_3_2","first-page":"64","article-title":"WNV testing in the US: summary of results for 2002 preclinical and 2003 clinical studies [abstract]","volume":"87","author":"Stramer S","year":"2004","journal-title":"Vox Sang"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038138"},{"key":"e_1_2_6_5_2","first-page":"916","article-title":"Update: detection West Nile virus blood donations\u2014United States 2003","volume":"52","author":"Centers for Disease Control and Prevention.","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_6_2","first-page":"281","article-title":"Update: West Nile virus screening blood donations transfusion\u2010associated transmission\u2014United States 2003","volume":"53","author":"Centers for Disease Control and Prevention.","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_7_2","volume-title":"SAS software.","year":"2001"},{"key":"e_1_2_6_8_2","first-page":"623","volume-title":"SAS language: reference dictionary","year":"1999"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-5931-2"},{"issue":"3","key":"e_1_2_6_10_2","first-page":"13","article-title":"West Nile Virus RNA screening of US blood donors: yield of minipool vs individual donation NAT [abstract]","volume":"87","author":"Cagliotti S","year":"2004","journal-title":"Vox Sang"},{"key":"e_1_2_6_11_2","first-page":":2A","article-title":"Yield of WNV positive donors from minipool and individual donation NAT in 2003 [abstract]","volume":"44","author":"Stramer SL","year":"2004","journal-title":"Transfusion"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04227.x"},{"key":"e_1_2_6_13_2","first-page":"139A","article-title":"Improved specificity of the Procleix WNV assay using a modified probe formulation [abstract]","volume":"44","author":"Linnen JM","year":"2004","journal-title":"Transfusion"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040085"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0041-1132.2005.04315.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0041-1132.2005.04315.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:45:42Z","timestamp":1697258742000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0041-1132.2005.04315.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,22]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1111\/j.0041-1132.2005.04315.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0041-1132.2005.04315.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,22]]}}}